BioVision acquisition helps lift Abcam in 2021

Life science supplier Abcam said in a trading update on Thursday that it expected total revenues of around £315m for 2021, representing growth of more than 22% at constant exchange rates, and 17% on a reported basis.

  • Abcam
  • 13 December 2022 17:24:29
Abcam

Source: Sharecast

The AIM-traded firm said that included a contribution of about £2.5m of incremental revenue from BioVision, following the acquisition's completion on 27 October.

It said revenue growth for the 12 months ended 31 December was driven by demand for its proprietary products, with in-house catalogue sales up 37% at constant currency on an organic basis, or 43% including BioVision, together with a continued recovery in global lab activity.

While risks related to the pandemic remained, Abcam said its data indicated that, while not yet returning to pre-pandemic levels, overall lab activity continued to increase through 2021.

The group said it continued to build capabilities, invest in innovation and implement its multi-year growth strategy throughout the period.

Overall, it said it was expecting adjusted operating profits in line with its expectations for the year, adding that it remained on track to achieve its financial goals for the five-year plan through 2024.

“2021 was a year of significant innovation and growth in proteomic tools and discovery - I thank our customers for trusting Abcam as their preferred partner and our global colleagues for their unwavering dedication to customer needs and aspirations,” said chief executive officer Alan Hirzel.

“Together, we are building a durable enterprise that is making a difference in the pace and social impact of discovery.

“I am confident in our progress toward our 2024 business goals and I look forward to providing the full update in March.”

Abcam said that, following the change in its financial year end to December, full results for the 18 months to 31 December would be released on 14 March.

In order to aid comparison, pro forma information for the 12 month periods ended 31 December in 2021 and 2020 would also be provided.

At 1547 GMT, shares in Abcam were up 1.57% at 1,293p.

N/A

Isin: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

Whether you're looking for a Share Dealing Account or Share Dealing ISA, we've got an account to suit your needs.

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2024 Refinitiv, an LSEG business. All rights reserved.